908 Devices Inc. reported $61M of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $61M (to Q2 2026). Net income: −$35M, trailing twelve months to Q2 2026. Free cash flow: $603K, trailing twelve months to Q2 2026. Operating margin: −69%, trailing twelve months to Q2 2026.

MASS908 Devices Inc.

Healthcare

$11.55+30% 1Y

$11.55

$5.0952 weeks$12.80

MASS as reported

908 Devices Inc. reported $61M of revenue over the trailing twelve months, +13% on the year before. 10 reported series are charted on this page, each one as filed.

$61M

Revenue, trailing twelve months · to Q2 2026 · +13% against the twelve months before

Net income: −$35M
Net income · +88% year on year · trailing twelve months to Q2 2026
Free cash flow: $603K
Free cash flow · −102% year on year · trailing twelve months to Q2 2026
Operating margin: −69%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for MASS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$61M	+13%	Q2 2026
Net income	−$35M	+88%	Q2 2026
EPS	−$0.94	+74%	Q2 2026
Gross margin	52%	n/a	Q2 2026
Operating margin	−69%	n/a	Q2 2026
Net margin	−62%	n/a	Q2 2026
ROE	−11%	n/a	Q2 2026
ROA	−7.2%	n/a	Q2 2026
ROIC	145%	n/a	Q4 2022 · 14 quarters behind
Free cash flow	$603K	−102%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.